1383570-59-9

Basic information

• Product Name: tert-butyl [(2R,5R)-5-amino-1,6-diphenylhexan-2-yl]carbamate
• Synonyms: tert-butyl [(2R,5R)-5-amino-1,6-diphenylhexan-2-yl]carbamate
• CAS NO: 1383570-59-9
• Molecular Weight: 368.519
• Mol File: 1383570-59-9.mol

Chemical Properties

• CAS DataBase Reference: tert-butyl [(2R,5R)-5-amino-1,6-diphenylhexan-2-yl]carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl [(2R,5R)-5-amino-1,6-diphenylhexan-2-yl]carbamate(1383570-59-9)
• EPA Substance Registry System: tert-butyl [(2R,5R)-5-amino-1,6-diphenylhexan-2-yl]carbamate(1383570-59-9)

Safety Data

• Hazardous Substances Data: 1383570-59-9(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 1383570-15-7 tert-butyl [(2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl]carbamate 
• 1383570-58-8 (S)-N-((2R,5R)-5-amino-1,6-diphenylhexan-2-yl)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamide hydrochloride 
• 1383570-16-8 C₃₈H₄₉N₅O₄S₂ 
• 1383570-23-7 C₃₆H₅₁N₅O₄S 
• 1383570-28-2 C₃₈H₅₅N₅O₃S 
• 1383570-60-2 tert-butyl 5-((5S,8R,11R)-8,11-dibenzyl-5-isopropyl-1-(2-isopropylthiazol-4-yl)-2-methyl-3,6,13-trioxo-14-oxa-2,4,7,12-tetraazapentadecan-15-yl)-1H-imidazole-1-carboxylate 
• 1383570-21-5 (1H-imidazol-5-yl)methyl [(2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl]carbamate 
• 1383570-19-1 oxazol-5-ylmethyl [(2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl]carbamate 
• 1383570-17-9 pyridin-3-ylmethyl [(2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl]carbamate 
• 144186-34-5 (2R,5R)-1,6-diphenylhexane-2,5-diamine 

Relevant articles and documents

NOVEL PROCESS FOR THE PREPARATION OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5- CARBAMOYL) AMINO] -4-(MORPHOLIN-4-YL)BUTANOYL]AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE

The present invention relates to novel processes for the preparation 1,3-Thiazol-5-ylmethyl[(2R,5R)-5-{[(2S)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl} carbamoyl)amino]-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl] carbamate having the following structural formula-1 and it's intermediates thereof.

Pyridine-substituted desoxyritonavir is a more potent inhibitor of cytochrome P450 3A4 than ritonavir

Utilization of the cytochrome P450 3A4 (CYP3A4) inhibitor ritonavir as a pharmacoenhancer for anti-HIV drugs revolutionized the treatment of HIV infection. However, owing to ritonavir-related complications, there is a need for development of new CYP3A4 in

INHIBITORS OF CYTOCHROME P450 (CYP3A4)

The present application provides for a compound of formula I, and related compounds, or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods that include the administration of such compounds with at least one additional therapeutic agent.